TSXV:TRL.H - Post by User
Comment by
LTOWNERon Jul 20, 2014 8:30am
304 Views
Post# 22763273
RE:AbbVie as potential partner for Natesto?
RE:AbbVie as potential partner for Natesto?I had the exact same thought mp! But then AbbVie has always been my Number One pick as a Partner for Trimel and Natesto. The Trimel/Shire deal came just one day before the AbbVie/Shire acquisition was announced. If the marketing and sales for Estrace in the Canadian market will still be done by Shire - then it will be done by AbbVie after AbbVie acquires Shire.
Novel drug delivery aside, AbbVie is the largest Testosterone Replacement supplier with about $1.5 billion in Androgel sales annually. By partnering with Trimel - Androgel-IN? - AbbVie will have the best product on the market, a product without a black box warning, a product that is far easier to apply, a product that can be used without fear of transference and the lowest dose of testosterone which must be better for any cardiac-associated issues. With AbbVie's sales for TRT already established for years, Natesto would hit the market by storm.